Abiopharma

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001415889-25-022074 Size: 5 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001437749-25-027147 Size: 7 KB

New Form 8-K - Syra Health Corp Filed: 2025-08-15 AccNo: 0001641172-25-024383 Size: 198 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 10-Q - Allarity Therapeutics, Inc. Filed: 2025-08-15 AccNo: 0001437749-25-027146 Size: 4 MB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001628280-25-040522 Size: 8 KB

New Form DEF 14A - Cingulate Inc. Filed: 2025-08-15 AccNo: 0001641172-25-024386 Size: 3 MB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001641172-25-024384 Size: 5 KB

New Form 424B5 - NEUROONE MEDICAL TECHNOLOGIES Corp Filed: 2025-08-15 AccNo: 0001213900-25-077495 Size: 20 KB

New Form 8-K/A - RxSight, Inc. Filed: 2025-08-15 AccNo: 0001111485-25-000003 Size: 148 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 8-K - Unicycive Therapeutics, Inc. Filed: 2025-08-15 AccNo: 0001213900-25-077497 Size: 195 KB Item 8.01: Other Events

New Form 8-K - Adaptimmune Therapeutics PLC Filed: 2025-08-15 AccNo: 0001558370-25-011616 Size: 205 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001723128-25-000051 Size: 8 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001493152-25-012099 Size: 5 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001415889-25-022072 Size: 11 KB

Schrödinger, Inc. - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)